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Abstract
The composition of the cellular proteome is commonly thought to strictly adhere to the genetic 
code. However, accumulating evidence indicates that cells also regulate the synthesis of mutant 
protein molecules that deviate from the genetic code. Production of mutant proteins varies in 
amounts and specificity and generally occurs when cells are stressed or undergo environmental 
adaptation. The deliberate synthesis of protein mutants suggests that some of these proteins can be 
useful in cellular stress response and adaptation. This review describes the occurrence, the 
translation mechanisms, and the functional hypotheses on regulated synthesis of mutant proteins.
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Introduction
A central pillar of molecular biology is the accuracy of information transfer from DNA to 
proteins. It is commonly believed that the genetic code should be obeyed at all times, and 
any derivation of this rule reflects the imperfection of the translation process. The translation 
fidelity is commonly cited as between 10-5 to 10-3 per codon, depending on the 
measurement method and the codon context (27, 35, 36, 43, 61, 79). These error frequencies 
are typically interpreted as the tolerance threshold of the translation machinery. Less 
accurate translation would result in the synthesis of proteins that deviate from the genetic 
code.
The translation fidelity is maintained at two steps: the accuracy of tRNA aminoacylation and 
the ribosome matching the mRNA codon with the tRNA anticodon (Fig. 1A). tRNA 
aminoacylation or charging is performed by aminoacyl-tRNA synthetases (aaRS); there is 
typically one aaRS for each amino acid in the cell. Each aaRS selects its cognate tRNAs 
among all tRNAs in the cell and chemically attaches its cognate amino acid to the 3′ end of 
the cognate tRNA. In general, tRNA synthetases are highly accurate: the fidelity of 
aminoacylation is typically better than 10-4 when measured in vitro using purified tRNA 
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synthetases (43). The ribosome matching mRNA codon with the correct tRNA anticodon 
involves Watson-Crick base pairing of the first and second codon nucleotide, and either 
Watson-Crick or wobble base pairing of the third codon nucleotide. The highly accurate 
matching involves many quality control steps and is typically on the order of 10-4 when 
measured in vitro using purified components (61, 79). For both aminoacylation and codon-
anticodon matching, a common theme has emerged that fine tuning of every step of the 
process is important to ensure high fidelity of translation.
An important consideration of translation fidelity is when a fine-tuned translational process 
may no longer be available in the cell. As early as the advent of two-dimensional gel 
electrophoresis in the 1970s, it was observed that under nutritional or environmental stress, 
cells often produce proteins that seem to deviate from those programmed by the genetic 
code (54). Starving E. coli for the amino acid asparagines (Asn) leads to readily detectable 
levels of proteins that contain non-Asn substitutions such as lysine (Lys, (56)). This result 
was interpreted as Asn starvation decreasing the amount of charged tRNAAsn (which reads 
AAC/AAU codons) so that the near-cognate tRNALys (which reads AAG/AAA codons) can 
read the Asn codons to make Asn-to-Lys mutant proteins. Mutant protein synthesis under an 
imbalance of charged tRNAAsn/tRNALys shows that there are potential advantages in 
making mutant proteins, which may be active in response to cell stress, over making no 
protein all. It is however not known whether any of the Lys-to-Asn mutant proteins serves a 
function distinct from the wild-type protein. A recent example of conditional dependence of 
synthesizing mutant proteins in mammalian cells shows that high level antibody production 
in Hamster cells leads to significant levels of Asn-to-Ser substituted antibody proteins as 
detected by mass spectrometry (74). This mutant protein production seems to be derived 
from insufficient supply of Asn in the growth medium: Asn supplement drastically reduces 
the amount of such mutant proteins.
Underappreciated until recently, cells and organisms have a high threshold of tolerance of 
decreased translational fidelity when one central component in translation is genetically 
mutated either in isolated mutant strains or occurring naturally, or expressed at inappropriate 
amounts. For example, the Ala734-to-Glu mutation in the mammalian Alanyl-tRNA 
synthetase (AlaRS) significantly increases the frequency of AlaRS charging of tRNAAla 
with serine or glycine (39). This high level of decreased translational fidelity is not lethal for 
homozygous mice bearing this genetic mutation, however. The known significant damage of 
these mice occurs in cerebellar Purkinje cells in the brain which is linked in some way to the 
accumulation of protein aggregates in these cells. This result also means though that a 
similar level of synthesis of mutant proteins does not induce comparable damage in many 
tissues and cell types. In E. coli, the expression of editing-deficient AspRS leads to 
significant generation of Asn-mischarged tRNAAsp which is then used in translation to 
generate Asp-to-Asn mutant proteins (62). Examining a reporter gene that is not under 
selection pressure shows that up to 10% of this substitution is tolerated in actively growing 
E. coli. In S. cerevisiae and E. coli, the expression of an editing-deficient PheRS leads to 
significant generation of Tyr-mischarged tRNAPhe (60). However, substitution of the wild-
type with the inaccurate PheRS in E. coli or in the cytosol of S. cerevisiae has little effect on 
growth in rich media. The inaccurate PheRS cannot replace the wild-type PheRS in yeast 
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mitochondria, indicating that different cellular compartment has distinct tolerance to 
translation accuracy.
The Candida branch of yeast contains a tRNA that is charged with serine but reads the CUG 
codon which codes for leucine in all other organisms (49, 64). Accordingly, all Candida 
species containing this tRNASer(CAG) gene have reprogrammed their genomes where CUG 
codes for serine. In Candida albicans, this tRNASer(CAG) is charged with serine at 95-97% 
and with leucine at 3-5%, and this charging heterogeneity is reflected by their incorporation 
into the Candida proteome (19). Interestingly, the tRNASer(CAG) from C. albicans can be 
expressed in a different yeast, Saccharomyces cerevisiae without causing lethality; it even 
benefits S. cerevisiae in responding to stress (63). In S. cerevisiae, tRNASer(CAG) is a de 
facto mutator-tRNA, it is still charged with Ser but competes with the endogenous 
tRNALeu(CAG) for decoding all CUG codons, resulting in the production of Leu-to-Ser 
mutant proteins. Yeast cells with low-fidelity proteomes do not fare as well as the wild-type 
cells under steady-state growth conditions. However, these cells do markedly better than the 
wild-type cells when challenged with chemical stressors. Making a lower fidelity proteome 
under steady-state growth elevates the production of stress response proteins such as hsp-
protein chaperones before these cells are challenged with a stressor, thereby increasing their 
tolerance to stress through induction of cross-protection mechanisms.
These results indicate that cells can not only produce mutant proteins beyond the commonly 
cited threshold of translational fidelity, but also tolerate the persistent presence of such 
proteins. In the case of tRNASer(CAG) in S. cerevisiae, the expression of this foreign tRNA 
even confers a benefit in stress response. Two questions immediately come to mind: Can 
cells naturally regulate translation of mutant proteins and also benefit from this process? 
And if yes, how? Affirmative answers to these questions would indicate that regulated 
synthesis of mutant proteins can serve a heretofore much under-appreciated role in cellular 
stress response and adaptation. This review will discuss known cases that support the 
hypothesis of regulated translation of mutant proteins serving beneficial functions and 
provide my personal perspectives on future challenges of the field.
How cells regulate translation of mutant proteins: tRNA aminoacylation
Translation fidelity can be changed in many ways through errors in tRNA aminoacylation or 
ribosome codon-anticodon matching, occurrences in ribosome frameshifting or readthrough, 
and cellular variations of protein factors involved in translation (Fig. 1B, 1C).
There are two major ways to decrease fidelity in tRNA aminoacylation by AARS. The first 
involves the attachment of non-cognate amino acid to cognate tRNA. This type of error 
arises because the chemical structures of some amino acids are similar and differ by as little 
as a methyl group. One extensively studied example of this type is the mischarging of Val to 
tRNAIle by IleRS (22, 25, 53). The amino acids Ile and Val differ by a single methyl-group. 
The smaller Val can fit in the active site of IleRS and is mischarged at ∼1% level as Ile. 
More than 99% of the mischarged Val-tRNAIle is subsequently eliminated by the IleRS 
because only the smaller Val can fit in the active site of IleRS's editing domain. The editing 
efficiency of AARS in vivo can vary in several ways. Several AARSs in Mycoplasma 
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parasites have natural mutations in their editing domains resulting in the inactivation of their 
editing activities (42). Proteomic mass spectrometry shows that the cellular proteomes in 
these bacterial parasites contain numerous mutations due to tRNA mischarging derived from 
these editing-defective AARSs. The generation of statistical proteomes in these bacteria may 
have a useful purpose that remains to be determined. The E. coli ThrRS has a conserved 
Cys-residue in its editing domain. This Cys-residue is sensitive to oxidation in vitro upon 
exposure to H2O2 and in vivo upon increasing intracellular concentration of reactive oxygen 
species (44). The Cys-oxidized ThrRS is defective in editing, thus generating a significant 
amount of serine mischarged tRNAThr which is used in translation in cells. Hence, the 
editing activity of ThrRS can be regulated during oxidative stress. Increased mischarging of 
tRNAThr results in Ser mis-incorporation, thereby producing misfolded proteins or 
generating potential new sites of phosphorylation. Such mutant proteins may be used in 
signaling pathways (44). Presumably, the wild-type ThrRS editing activity can be restored 
once the cells are no longer under oxidative stress.
The second way to decrease tRNA charging fidelity involves the attachment of cognate 
amino acid to non-cognate tRNA. This type of error arises because in cells, cognate tRNAs 
for each AARS are present together with all non-cognate tRNAs for the 19 other AARSs. 
Although the cognate AARS recognizes the identity element for their cognate tRNAs for 
positive identification, it must also avoid aminoacylation of non-cognate tRNAs. It was 
recognized in 1988 that individual tRNA concentrations and their cognate synthetases need 
to be properly balanced to avoid mischarging in vivo (71). In E. coli, overexpression of 
GlnRS leads to increased mischarging of a non-cognate tRNA with Gln; this mischarging is 
suppressed upon overexpression of tRNAGln at the same time. The Candida albicans 
tRNASer(CAG) reads CUG codons; it is mostly charged with serine, but also with 3-5% 
leucine in vivo depending on the cellular conditions (19). Since both Ser-tRNASer(CAG) and 
Leu-tRNASer(CAG) are used in translation, the proteome of C. albicans contains many 
proteins with either Ser or Leu at all CUG-codons. Expression of a foreign tRNALeu(CAG) 
in C. albicans results in up to 28% CUGmiscoding, and yet, C. albicans growth measured in 
the laboratory is not significantly impaired. Increasing CUG-miscoding using the foreign 
tRNALeu(CAG) leads to significantly larger diversity in colony morphologies, indicating 
that a more diverse proteome generated through ambiguous decoding can lead to phenotypic 
diversity (47). The C. elegans genome contains a tRNAGly and a tRNAIle gene with an 
additional stem-loop in the variable arm (7). tRNAs with a stem-loop in the variable arm 
(type II tRNA) are generally restricted to tRNALeu and tRNASer in eukaryotes, and all other 
tRNAGly and tRNAIle genes in C. elegans have a standard, short variable loop. The type II-
tRNAGly and tRNAIle are expressed in C. elegans; but in vitro, they are charged with Leu 
and decode the corresponding Gly and Ile codons in translation (24). Thus, C. elegans and a 
few other worm species seem to contain mutator-tRNAs that read codons in different ways 
as dictated by the genetic code.
A recent discovery shows that mammalian cells contain many non-methionyl-tRNAs 
mischarged with methionine at levels that are highly regulated ((52); Fig. 2). The baseline 
misacylation for methionine in unstressed cells, i.e. the fraction of Met attached to 
nonmethionyl tRNA, is ∼1%, or at least 100-fold higher than expected for commonly cited 
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fidelity for AARSs (<0.01% or 10-4). Remarkably, following infection of cells with several 
drastically different viruses, Met misacylation rises to up to ∼10%. Active virus infection is 
not required for this effect, but rather, misacylation is induced by Toll-like receptor (TLR) 
ligands, including inactivated virions, poly-IC, CpG oligonucleotides, and 
lipopolysaccharides. Induced misacylation above basal levels can also be triggered by 
exposure to oxidative chemicals such as H2O2 or arsenite. Induction of misacylation is 
inhibited in the presence of a small molecule inhibitor for a broad family of human NOX 
proteins which are NADPH oxidases capable of rapid production of reactive oxygen species 
(ROS). These results indicate that ROS is the cellular trigger of tRNA misacylation with 
Met. Met misacylation is selective for certain tRNA families and does not correlate with 
their abundance in cells. tRNA misacylation seems to be restricted to Met, as no 
misacylation was detected for amino acids Cys, Ile, Phe, Tyr or Val. The Met-misacylated 
tRNAs are used in translation as analyzed by global charged tRNA turnover kinetics, 1D and 
2D gel electrophoresis and mass spectrometry of proteins.
Additional studies show that the Met-misacylation is derived from the activity of methionyl-
tRNA synthetase (MetRS). Recombinant E. coli MetRS misacylates two E. coli tRNA 
species in vitro (31). Further, E. coli MetRS mutants have been found that either increase or 
decrease the level of misacylation in vitro, suggesting misacylation by MetRS is a tunable 
activity of this enzyme. Met misacylation is also present in S. cerevisiae, and the 
recombinant yeast tRNA synthetase complex made of one subunit each of MetRS, GluRS 
and Arc1p protein misacylates numerous yeast tRNA species in vitro (75).
Are all misacylated tRNAs used in translation in vivo? A major mechanism known to 
selectively deliver correctly charged tRNAs into the A-site of ribosome is their selective 
binding by the bacterial elongation factor EF-Tu, also known as the EF-Tu filter (9, 15, 38). 
EF-Tu has separate binding affinities for the tRNA body and the 3′ attached amino acid. The 
free energy of both binding affinities adds up equally for correctly charged tRNAs, whereas 
incorrectly charged tRNA can bind too strongly, too weakly or similarly to correctly charged 
tRNAs. In vitro, the E. coli EF-Tu does not deliver strongly or weakly bound tRNAs to the 
ribosome. The extent of this discrimination remains to be determined in vivo where some 
mischarged tRNAs are shown to be used for protein synthesis at appreciable frequencies as 
analyzed by reporter gene activities or mass spectrometry of reporter proteins. Whether the 
eukaryotic homologue of EF-Tu, EF-1α, discriminates mischarged tRNA is unclear. At least 
some misacylated tRNAs seem to be used for protein synthesis in yeast and in mammalian 
cells (e.g. (52, 75)).
How cells regulate translation of mutant proteins: ribosome decoding
Altering translational fidelity on the ribosome can occur in several ways. One way is 
mismatching an mRNA codon with a tRNA anticodon, causing an amino acid substitution. 
Codon-anticodon mismatch can result through the imbalance of available, charged cognate 
tRNAs either through improper balance of tRNA abundance or selectively decreased tRNA 
charging levels in specific tRNAs. For example, charging levels of certain tRNAs can drop 
dramatically during amino acid starvation of the cell (12, 68, 78). The decreased availability 
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of cognate, charged tRNAs increases the frequency of A-site entry of near-cognate tRNAs 
whose charging is not perturbed under these conditions.
Alterations in translational fidelity can also depend on the extent of specific tRNA 
modifications. Oxidative and methylation stresses in yeast induce highly dynamic variations 
of tRNA modification (5). For example, 5-methyl-C (m5C) modification in total yeast tRNA 
can increase or decrease depending on the type and severity of stress. This dynamic 
variation is biologically important as the m5C-modification enzyme knockout yeast strain is 
less tolerant to certain stresses. The m5C34 wobble modification in tRNALeu(CAA) 
selectively enhances translation of the UUG codons which are over-represented in numerous 
yeast proteins that are translated in response to oxidative stress (6). Another dynamic yeast 
modification involves methylation of the hypermodified U34 wobble in tRNAArg(UCU) and 
tRNAGlu(UUC) (2). This modification is inducible upon DNA damage and is necessary to 
maintain translation fidelity at codons read by the hypermodified tRNAArg(UCU) (57).
Hypomodification in specific tRNAs can also increase ribosomal frameshifting and stop 
codon readthrough. A well-characterized example is the N1-methyl-G37 (m1G) modification 
in several bacterial tRNAs which occurs at the immediate 3′ residue to the anticodon (3, 4). 
m1G37 modification reduces frameshifting frequencies for tRNAs that read codons with C 
in their first position (e.g. tRNAPro), because this modification prevents incorrect pairing 
with a C in the third position of the preceding codon. m1G modification is essential in 
bacteria; its complete loss is lethal to the cell.
How cells regulate translation of mutant proteins: mRNA and translation 
factors
The presence of certain mRNA structures or alteration of specific translation factors can also 
increase the frequency of ribosomal frameshifting and stop codon readthrough. Ribosome 
frameshifting or stop codon readthough is essential for the life cycle of mammalian 
retroviruses (16, 18). The structural genes of retroviruses (gag proteins) are linked with the 
catalytic genes (pol proteins) in a single mRNA transcript. To balance the amount of gag 
versus pol proteins, the pol proteins are produced at frequencies of ∼5-10% to gag proteins 
through ribosome frameshifting or stop codon readthrough as directed by specific mRNA 
structures in the viral mRNA.
Another way of altering translational fidelity is by reducing the amount of available protein 
factors through protein aggregation such as prion formation (23, 66, 72, 73). In yeast, prion 
formation is an inducible process where specific, soluble proteins are incorporated into 
aggregated states. One prion protein is Sup35 which is a release factor required for 
translational termination. Under specific conditions the N-terminal domain of Sup35 allows 
this protein to switch into an alternative conformation, leading to an aggregated prion-like 
state. Sup35 prion formation reduces the amount of available release factors which leads to 
stop codon readthrough at numerous genes. This process can be beneficial in yeast response 
to certain stresses, presumably because some of the new protein C-terminal extensions could 
be specifically useful in stress response. Another yeast prion protein is the tRNA N6- 
isopentenyl-A37 (i6A37) modification enzyme (70). i6A37 may control translation fidelity 
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of decoding and the frequency of frameshifting using a mechanism similar to the m1G37 
modification in bacterial tRNAs.
How cells regulate translation of mutant proteins: to be determined
Significant, dynamic fluctuations in the frequency of frameshifting and stop codon 
readthrough have been observed in the bacterium Bacillus subtilis using a GFP reporter and 
an antibiotic resistance gene (46). The frequency of frameshifting and stop codon 
readthrough depends on cellular conditions such as growth temperature, cell density or the 
presence of antibiotics. Although the mechanism of regulating translational fidelity in this 
case remains to be determined, it may be derived from dynamic variations in specific tRNA 
modifications, the availability of active release factors or something else.
Mistranslation dependent protein aggregation is a major cause of cell toxicity upon 
chromium stress (26). These protein aggregates are derived from newly synthesized proteins 
during chromium exposure. For example, the frequency of stop codon readthrough 
significantly increases, although this increase only occurs under aerobic conditions. The 
mechanism for altering translational fidelity upon chromium exposure remains to be 
elucidated; it may be derived from altered activity of release factors or dynamic variations in 
tRNA modifications.
Significant, genome-wide changes in frameshifting and stop codon readthrough have also 
been observed in yeast upon oxidative stress using the ribosome profiling technique (17). 
Ribosome profiling is a recently developed high-throughput method that determines the 
actively translating mRNAs at single codon resolution (28, 29). Frameshifts can be 
identified when ribosome density shifts its periodicity from the annotated coding sequences 
and/or drops off at an alternate stop codon. Stop codon readthrough can be identified when 
significant ribosome density is present past the annotated stop codon and drops off at a 
downstream stop codon. Although the mechanism of regulating translational fidelity in 
oxidative stress in yeast remains to be determined, it may again be derived from dynamic 
variations in specific tRNA modifications, the availability of active release factors or 
something else.
A potential mechanism in regulating the synthesis of mutant proteins involves mRNA 
modification with pseudo-uridine (Ψ, (33)). The first nucleotide of all three stop codons is 
Uridine. Modification of U to Ψ in all three stop codons leads to high levels of stop codon 
readthrough, and each Ψ-modified stop codon specifically codes for two amino acids. 
Computational analysis suggests that Ψ-modified sense codons can be recoded; for example, 
the standard UUU codes for Phe, but ΨUU may be read as Cys/Tyr by the ribosome (55). Ψ 
is a major modification in tRNA, rRNA and spliceosomal RNA (8). Ψ may also occur in 
mRNA, although the location and the frequency of Ψ modification in mRNA remain to be 
determined.
How cells benefit from making their own mutant proteins
Proteins produced through the mechanisms described above generally are not uniform 
molecules. They are either protein families that share a large degree of similarity in case of 
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mutations, or groups of diverse protein species that share common domains in case of 
frameshift and stop codon readthrough. A common assumption for proteins generated 
through strictly obeying the genetic code is that each of these protein molecules is intended 
to perform useful function for the cell. In contrast, it is highly unlikely that every mutant 
protein produced by the cell is functional; in fact, some mutant proteins can be harmful to 
the cell either by nonspecific mechanisms such as aggregate formation, or possibly by 
dominant-negative functions. Nevertheless, since cells can produce appreciable amounts of 
mutant proteins in a regulated manner, can some of these mutant proteins serve beneficial 
functions for the cell? Several distinct fates for the mutant proteins can be envisioned, 
ranging from harmful to beneficial (Fig. 3):
i. Neutral: many mutant proteins fold correctly and are treated as regular proteins in 
cells. For example, tRNA misacylation with Met results in the generation of protein 
mutants that contain at most one Met substitution of non-Met residues in an 
average sized protein (52). Among others, these mutant proteins substitute a 
charged amino acid on the surface (e.g. Lys, Asp, Glu), or an internal hydrophobic 
amino acid (e.g. Leu, Val) with Met. Since the chemical property of the Met side 
chain is both hydrophobic and polar, many Met-substituted proteins likely fold like 
the wild-type protein.
ii. Harmful through aggregation: mutant proteins with amino acid substitution of 
distinct chemical properties can lead to conformational change and aggregation. 
For example, AlaRS mutant that loses its editing activity misacylates tRNAAla with 
Ser, resulting in substituting Ala, a small hydrophobic amino acid with Ser, a polar 
amino acid. Over time, some of these mutant proteins accumulate in aggregates 
which are linked to damage of specific neurons (39).
iii. Unfolded protein response: mutations leading to misfolded proteins are one of 
many mechanisms that trigger cellular response to unfolded proteins. This is a 
commonly discussed benefit of deliberate or increased production of mutant 
proteins (13, 21, 50, 59, 65). Since the mutant proteins from one single mRNA are 
not confined to one single sequence, there is a good chance that some of these 
proteins would misfold and thereby enhance the cellular unfolded protein response.
iv. Protein fragments as ligands: A possible benefit of making mutant proteins is that 
some mutants misfold and can therefore be rapidly recognized by the cellular 
protein degradation machinery which degrades the full-length protein to generate 
protein fragments. For example, in mammalian cells rapid degradation of newly 
synthesized, misfolded proteins by the proteosome can immediately produce 
peptides that are loaded onto Major Histocompatibility Complexes (MHC) for 
antigen presentation. This deficient ribosome product (DRIP) mechanism enables 
constant survey of cellular translation status by immune cells (77). It is also 
conceivable that some protein fragments produced through degradation 
immediately upon synthesis could become ligands for other cellular components in 
e.g. signal transduction.
v. Mutant proteins that benefit directly: A few specific mutant protein molecules 
could directly benefit the cells because of the actual sequence of mutation. For 
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example, the yeast prion state has substantially increased frequency of frameshift 
and readthrough. The prion state enhances the synthesis of antizyme by modulating 
frameshift required for its production (51). Antizyme is a negative regulator of 
polyamine biosynthesis, and the prion-induced translational control of antizyme 
significantly affects the cellular content of polyamines.
We have proposed a beneficial hypothesis for Met-substituted mutant proteins directly 
benefiting cells in response to oxidative stress (Fig. 4). This hypothesis is based on the 
unique property of Met which can be oxidized by ROS, but also reduced by peptidyl-Met 
sulfoxide reductases in cells (Fig. 4A, (41, 45, 48)). Many enzymes contain active site 
residues such as Trp, His or Cys that can be oxidized by ROS. ROS diffuses like water and 
can oxidize an active site residue resulting in permanent inactivation of the enzyme. To 
avoid this from occurring often, some proteins contain genetically encoded, strategically 
located Met residues that readily react with ROS before it gets into the active site (Fig. 4B). 
This process is reversible since the oxidized Met residues can be reduced by the MSRa/b 
proteins.
For each protein coding gene, high fidelity translation produces identical protein molecules; 
in contrast, the use of Met-misacylated tRNAs in translation produces a library of protein 
molecules. Individual molecules in this library are highly similar to each other and most can 
remain biologically active, but they differ in having on average one extra Met residue 
distributed throughout the protein molecule (52). Within this library, some mutant molecules 
could be better protected against oxidation than the wild-type molecule, because the extra 
Met residue in these mutants can be strategically localized to augment protection. For 
example, this extra Met residue may be placed on the opposite side of the active site groove 
relative to the genetically encoded Met residues (Fig. 4C). In this way, cells can ensure that 
some molecules derived from the same gene needed to respond to a wide and distinct range 
of oxidative stresses are more resistant to oxidative inactivation. By enabling some 
individual protein molecules to remain active under all conditions, this protein library 
approach produced at low translational fidelity may enable better cellular adaptation to 
stress compared to the uniform protein approach produced at high translational fidelity.
Another important issue in stress response is time (Fig. 4D). When response is present at 
time zero, cells activate signal transduction pathways that send signals to the nucleus in 
order to synthesize new mRNAs and then new proteins to respond to stress. This nuclear-
response to stress works very well; but it generally takes some time for these stress response 
proteins to take over. In mammalian cells, the nuclear response takes on the order of hours 
to be fully active, so cells must respond by other means first to buy time. The mechanism of 
tRNA misacylation with Met is well suited for this purpose. Charged tRNAs turn over on 
the second time scale in mammalian cells (30, 76). Thousands of human genes undergo 
translational regulation, so that many mRNAs are already present in the cytoplasm prior to 
the exposure of the stressor. These mRNAs can be translated within seconds or minutes to 
produce Met-substituted mutant protein libraries. Each library contains a few individual 
protein molecules with additional, strategically located Met-residues. These individual 
protein mutants are therefore better protected and should remain active longer than the wild-
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type proteins. These mutants need only remain active long enough for the nuclear response 
to arrive.
To quickly regulate tRNA misacylation with Met, we hypothesize that the cellular MetRS 
exists in at least two forms that differ in post-translational modifications. The hypomodified 
form aminoacylates at high fidelity and this form dominates in unstressed cells. Upon 
oxidative stress, some MetRS molecules become modified at specific residues, and the 
modified form aminoacylates at low fidelity. An important aspect of this hypothesis is 
reversible regulation: the modification that generates the low fidelity form of MetRS can be 
reversed when the stress has been dealt with. Potentially reversible modifications include 
phosphorylation/dephosphorylation carried out by protein kinases/phosphatases, or Cys/Met 
oxidation/reduction. Since the low fidelity form is supposed to increase upon elevated ROS 
levels which can directly oxidize Cys or Met residues, no enzymes may be needed to 
generate the low fidelity form of MetRS. The reduction of Cys can be carried out by cellular 
small molecule reductants or thioredoxin proteins, and the reduction of Met can be carried 
out by the MSRa/b proteins.
Future perspectives and challenges
Translational errors have been generally categorized as mistranslation in the past. The term 
“mistranslation” however implies that translational errors are solely mistakes to be avoided. 
As described here and in previous reviews (14, 50, 59, 77), sufficient evidence exists that 
point to useful applications for some of the mistranslated proteins. I tentatively use the term 
“adaptive translation” to describe mistranslation events that generate mutant proteins that 
play functional roles because of their specific mutated sequences (Fig. 3). Adaptive 
translation seems to be prevalent and inducible under stress, suggesting that a primary 
function of adaptive translation is for cellular stress response.
Once an adaptive translation process has been identified, several questions need to be 
addressed to fully evaluate the functional significance and the regulatory mechanisms. Using 
the tRNA misacylation with Met as an example, I describe below four questions that 
represent major challenges for the field.
i. What is the regulatory mechanism? tRNA misacylation with Met is carried out by 
methionyl-tRNA synthetases. However, cellular conditions have been found where 
the extent of misacylation can be anywhere between 10% to below detection by the 
microarray method, <0.025% (unpublished results), indicating that the fidelity of 
MetRS in cells is highly regulatable. One model of this regulation is through post-
translational modification of MetRS. The mammalian MetRS is known to be 
phosphorylated and Cys-oxidized (37, 40, 58), any one of these modifications may 
alter the tRNA charging fidelity of this enzyme. Another model is through 
association/dissociation of MetRS with other cellular components. The mammalian 
MetRS is a subunit of an eleven protein complex, but it can also dissociate from 
this complex in cells (34, 37). This 11-protein complex is also known to associate 
with polysomes (10, 32, 69), and this polysome association is dependent on active 
translation of the mRNA in cells (10).
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Identification of the regulatory mechanism will enable the construction of MetRS 
mutants that still perform its essential, housekeeping function of charging 
tRNAMet, but can no longer misacylate non-Met-tRNAs. These MetRS mutants 
will be crucial in the studies of phenotypic responses that benefit the organism.
ii. What is the fitness benefit? Once a mutant MetRS is identified that cannot 
misacylate tRNAs in response to stress, bacterial or yeast strains or mammalian cell 
lines can be constructed where this mutant replaces the wild-type MetRS gene. 
These strains will allow for testing the physiological response of tRNA 
misacylation with Met. For example, our functional hypothesis (Fig. 4C) predicts 
that cells that can no longer misacylate tRNA should have a longer delay in early 
response to and will take longer to recover from oxidative stress.
iii. What is the selectivity of the adaptive-translated proteome? Although we expect 
that many misacylated tRNA with Met are used by the ribosome, not all 
misacylated tRNAs will be used equally as the correctly charged tRNAs in protein 
synthesis. Some misacylated tRNAs with Met may not be efficiently delivered to 
the A-site by the elongator factor. Most studies on translational errors on the 
ribosome so far investigated ribosome proofreading upon codonanticodon 
mismatch. Misacylated tRNAs however can form perfect matches in codon-
anticodon pairing. The ribosome may reject certain misacylated tRNAs because the 
amino acid and tRNA mismatch may not allow for efficient peptide bond 
formation, although how extensive this occurs remains to be determined. 
Understanding the ribosome's usage of misacylated tRNAs will lead to new 
decoding rules for protein synthesis that do not strictly adhere to the genetic codes.
iv. What are the specific protein molecules that use adaptive translation to confer 
benefit?Adaptive translation using misacylated tRNAs with Met can generate 
protein libraries from many genes. Clearly, not all protein molecules in these 
libraries are useful for the cell. A functional hierarchy likely exists where protein 
libraries from a few genes confer a great deal of benefit, whereas libraries from 
many genes are neutral in functional significance. Furthermore, only a fraction of 
all members within each beneficial library would be useful for stress response. 
These particular members may have the extra Met-residue located at strategic 
positions to enhance their survivability under oxidative stress. Hence, the actual 
sequences of these mutant molecules matter. Identification of the functionally 
beneficial libraries and the specific mutant sequences within these libraries that 
truly matter will be necessary to understand the significance and the physiological 
response derived from adaptive translation.
Concluding remarks
For a long time, translational errors have been commonly thought to be avoided at all times. 
Recent results indicate that cells actively regulate translational errors, potentially for 
beneficial purposes such as in the response to stress. Among the two other processes in the 
central dogma of molecular biology, decreasing the fidelity of replication and transcription 
has already been shown to be beneficial in certain circumstances. For example, somatic 
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hypermutation reduces the fidelity of DNA replication by over 1,000-fold and enables B-
cells to generate diverse libraries of receptors and antibodies (11, 20). The ∼100-fold lower 
fidelity of retroviral reverse transcriptase enables the generation of diverse population of 
retroviruses, some of which can better resist cellular and pharmacological attacks (1, 67). It 
should not be surprising that cells could have also evolved to use regulated translational 
errors for stress response and adaptation (14, 50, 59, 77). I am confident that adaptive 
translation will be found to be more wide spread than currently known, and I eagerly 
anticipate that many more discoveries will be made in the near future.
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i. Protein synthesis errors occur frequently, especially during stress.
ii. Cells can tolerate a high level of protein synthesis errors than commonly 
assumed.
iii. Cells actively regulate protein synthesis errors.
iv. Mechanisms of altering protein synthesis errors include variations in tRNA 
misacylation, ribosome misdecoding, activity of release factors and others to be 
determined.
v. Some mistranslated protein molecules may benefit cells in stress response and in 
adaptation.
vi. A potential benefit for mistranslated proteins is in response to oxidative stress, 
e.g. in response to changes in reactive oxygen species in cells.
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i. There are four key questions to be addressed to fully establish the biology of 
adaptive translation.
ii. What are the regulatory mechanisms?
iii. What are the fitness benefits for the cell and for the organism?
iv. What are the selectivities of the adaptive-translated proteome?
v. What are the specific protein molecules that use adaptive translation to confer 
benefit?
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Fig. 1. Processes in protein synthesis that deviate from the genetic code
(A) Two steps in translation where translational fidelity is controlled (tRNA charging and 
ribosome decoding). AA: amino acid. (B) Mechanisms in making mutant proteins. (C) 
Mechanisms in making proteins through frameshift or stop codon readthrough.
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Fig. 2. tRNA misacylation with Methionine
(A) tRNA misacylation with Met in mammalian cells is regulated by reactive oxygen 
species (ROS) which can be generated from both exogenous and endogenous sources. (B) 
HeLa cells exhibit a basal level of misacylation which increases further by ∼10-fold upon 
full induction. tRNA misacylation is detected by microarrays of total charged tRNA from 
cells pulse-labeled with 35S-Met (52). Array probes for tRNAMets are shown as black dots in 
the array layout. (C) In the codon tables, codons read by misacylated tRNAs under 
uninduced conditions are shown in red and under induced conditions are in red and pink. 
Met codon is in blue.
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Fig. 3. Mutant proteins affect cells in many ways
Perhaps the least explored and least understood of these is when mutant proteins benefit 
cells directly because of their specific sequences. This process is defined as adaptive 
translation in this review because these specific proteins could help cells adapt to stresses or 
new environments.
Pan Page 21













Fig. 4. A functional hypothesis on Met-substituted mutants being useful in oxidative stress 
response
(A) Met-residues in proteins can undergo reversible oxidation by ROS and reduction by 
MSRa/b enzymes. (B) The E. coli EF-Tu (PDB 1efc) has two strategically positioned Met-
residues (shown in brown) that protect the active site (bound GDP shown in cyan) from 
ROS oxidation. Other Met-residues in EF-Tu are shown in yellow. (C) A member in the 
Met-substituted protein library can get an extra Met-residue located at the right place (e.g. 
the position indicated by the brown ball) that offers extra protection. This particular mutant 
molecule should be more resistant against ROS inactivation. (D) tRNA misacylation-based 
translation may help buy time before the full engagement of the nuclear response.
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